Rexall Sundown Cellasene Sales Reach $35 Mil. In Third Quarter
This article was originally published in The Tan Sheet
Executive Summary
Reflecting retailers' initial pipeline purchases, sales of the Cellasene cellulite-reducing dietary supplement were $35 mil. for the fiscal third quarter (ended May 31), an "all-time record" for the company, Rexall Sundown said during a June 15 teleconference. Initial Cellasene sales exceeded the firm's previous record of $32 mil. for Osteo Bi-Flex in the fourth quarter of fiscal 1998.